Does TIRAGOLUMAB Cause Hyponatraemia? 8 Reports in FDA Database

Q: Does TIRAGOLUMAB cause Hyponatraemia?

8 reports of Hyponatraemia have been filed with the FDA for TIRAGOLUMAB, representing 1.4% of all TIRAGOLUMAB adverse event reports.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Hyponatraemia have been filed in association with TIRAGOLUMAB. This represents 1.4% of all adverse event reports for TIRAGOLUMAB.

Reports of Hyponatraemia with TIRAGOLUMAB

1.4%

of all TIRAGOLUMAB reports

Deaths

Hospitalizations

How Dangerous Is Hyponatraemia From TIRAGOLUMAB?

Of the 8 reports, 7 (87.5%) required hospitalization, and 2 (25.0%) were considered life-threatening.

Is Hyponatraemia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TIRAGOLUMAB. However, 8 reports have been filed with the FAERS database.

What Other Side Effects Does TIRAGOLUMAB Cause?

Off label use (58) Hyperthyroidism (39) Pneumonia (29) Pneumonitis (26) Infusion related reaction (23) Intentional product use issue (23) Death (21) Adrenal insufficiency (20) Troponin increased (20) Colitis (15)

What Other Drugs Cause Hyponatraemia?

FUROSEMIDE (3,127) HYDROCHLOROTHIAZIDE (2,138) OMEPRAZOLE (1,635) LANSOPRAZOLE (1,416) SERTRALINE (1,332) RAMIPRIL (1,178) SPIRONOLACTONE (1,166) PANTOPRAZOLE (1,134) INDAPAMIDE (976) AMLODIPINE (879)

Which TIRAGOLUMAB Alternatives Have Lower Hyponatraemia Risk?

TIRAGOLUMAB vs TIRBANIBULIN TIRAGOLUMAB vs TIRZEPATIDE TIRAGOLUMAB vs TISLELIZUMAB TIRAGOLUMAB vs TISOTUMAB VEDOTIN TIRAGOLUMAB vs TISOTUMAB VEDOTIN-TFTV

TIRAGOLUMAB Full Profile All Hyponatraemia Reports All Drugs Causing Hyponatraemia TIRAGOLUMAB Demographics